DTRA Funds MerLion-Led Project to Counter Biological Threat Agents
A joint project of MerLion Pharmaceuticals and the Defence Science and Technology Laboratory has received a grant from the Defense Threat Reduction Agency to study the effectiveness of an antibiotic called finafloxacin against biological threat agents. The Singapore-based biopharmaceutical company said Wednesday the project will explore the effectiveness of MerLion’s fluoroquinolone finafloxacin against infections caused by […] More